Danaher, Blackstone Pursue Possible $4 Billion Joint Bid for Johnson & Johnson Unit

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Healthcare conglomerate Danaher Corp (DHR.N) has teamed up with Blackstone Group LP (BX.N) to bid for Johnson & Johnson's (JNJ.N) diagnostics unit, which makes blood screening equipment and laboratory blood tests and could fetch more than $4 billion, according to people familiar with the matter. The Danaher-Blackstone consortium is competing against several private equity bidders for J&J's Ortho Clinical Diagnostics unit, including Bain Capital LLC; Carlyle Group LP (CG.O); BC Partners Ltd; and a partnership of CVC Capital Partners Ltd and Leonard Green & Partners LP, the people said. J&J, which received preliminary offers for the division in late September, is seeking a new, interim round of bids by November 11, the people said on Thursday, asking not to be named because the matter is confidential.

Help employers find you! Check out all the jobs and post your resume.

Back to news